Heart Test Laboratories I...

NASDAQ: HSCS · Real-Time Price · USD
3.38
-0.12 (-3.43%)
At close: Aug 15, 2025, 3:38 PM

Heart Test Laboratories Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021
Revenue
4.35K n/a n/a n/a n/a 14.7K 3.9K n/a 5.14M 1.95K n/a 3.2K 4.15K 2.74K n/a 7.48K 14.95K
Cost of Revenue
1.88K -67.73K 34.41K 33.32K 9.2K 8.28K 1.52K 7.34K 2.79M 760.00 6.81K 2.04K 1.28K 854.00 6.6K 5.76K 6.22K
Gross Profit
2.47K 67.73K -34.41K -33.32K -9.2K 6.42K 2.38K -7.34K 2.35M 1.19K -6.81K 1.16K 2.87K 1.89K -6.6K 1.73K 8.73K
Operating Income
-1.92M -2.37B -1.99M -2.08M -1.88M -1.53M -1.57M -1.33M -1.6M -1.31M -1.77M -1.43M -1.98M -1.1M -956.86K -674.45K -786.24K
Interest Income
n/a 14.66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.09M -2.54B -2.08M -2.05M -1.85M -1.64M -1.75M -1.37M -1.63M -1.34M -1.81M -1.57M -2.05M -1.24M -1.03M -501.85K -851.57K
Net Income
-2.09M -2.54B -2.08M -2.05M -1.85M -1.64M -1.75M -1.37M -1.67M -1.37M -1.84M -1.72M -2.13M -1.24M -1.03M -501.85K -851.57K
Selling & General & Admin
993.78K 1.34B 786.07K 850.74K 833.68K 1.02M 815.02K 765.02K 1.06M 667.24K 925.93K 997.06K 625.05K 403.16K 411.08K 275.06K 202.07K
Research & Development
929.09K 1.03B 1.2M 1.22M 1.05M 509.51K 757.3K 565.63K 534.44K 643.26K 848.98K 434.2K 1.36M 699.01K 545.77K 401.11K 593.99K
Other Expenses
n/a -2.37B n/a n/a n/a 16.00 3.00 60.00 255.00 -7 1.2K 401.00 1.71K 851.00 n/a n/a -1.22K
Operating Expenses
1.92M 2.37M 1.99M 2.04M 1.88M 1.53M 1.57M 1.33M 1.6M 1.31M 1.77M 1.43M 1.98M 1.1M 956.86K 676.17K 796.06K
Interest Expense
180.85K 179.48K 117.6K 22.53K 20.94K 118.44K 178.44K 36.26K 33.96K 32.8K 32.8K 143.61K 77.03K 139.07K 77.91K 77.61K 64.12K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.92M 2.37M 1.99M 2.08M 1.88M 1.54M 1.57M 1.33M 1.6M 1.31M 1.77M 1.43M 1.98M 1.1M 956.86K 681.93K 802.28K
Income Tax Expense
n/a n/a n/a n/a n/a 3.00 n/a n/a 34.21K 32.81K 31.61K 143.21K 75.33K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.11M 986.06K 917.45K 777.75K 676.6K 537.93K 109.39K 103.32K 101.18K 83.5K 82.11K 56.19K 33.24K 33.23K 33.14K 33.14K 33.14K
Shares Outstanding (Diluted)
1.11M 986.06K 917.45K 777.75K 676.6K 537.93K 109.39K 103.32K 101.18K 83.5K 82.11K 56.45K 33.24K 33.23K 33.14K 33.14K 33.14K
EPS (Basic)
-1.88 -2.57 -2.27 -2.64 -2.73 -3.06 -15.98 -13.23 -16.47 -16.47 -22.39 -30.55 -64.04 -37.27 -31.23 -15.14 -25.7
EPS (Diluted)
-1.88 -2.57 -2.27 -2.64 -2.73 -3.06 -15.98 -13.23 -16.47 -16.47 -22.39 -30.41 -64.03 -37.27 -31.23 -15.14 -25.7
EBITDA
-1.88M -2.33M -1.99B -2M -1.82M -1.52M -1.56M -1.32M -1.59M -1.3M -1.77M -1.42M -1.97M -1.09M -950.25K -417.27K -780.21K
EBIT
-1.91M -2.36M -1.97M -2.03M -1.83M -1.53M -1.57M -1.33M -1.6M -1.31M -1.77M -1.43M -1.98M -1.1M -956.86K -424.25K -787.46K
Depreciation & Amortization
31.26K 28.97K -1.98B 33.32K 76.44K 3.72K 7.64K 7.34K 6.83K 6.87K 6.81K 6.41K 6.5K 6.5K 6.6K 6.97K 7.25K